Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

6 results about "Cysteine" patented technology

Cysteine (symbol Cys or C; /ˈsɪstiiːn/) is a semiessential proteinogenic amino acid with the formula HO₂CCH(NH₂)CH₂SH. The thiol side chain in cysteine often participates in enzymatic reactions, as a nucleophile. The thiol is susceptible to oxidation to give the disulfide derivative cystine, which serves an important structural role in many proteins. When used as a food additive, it has the E number E920. It is encoded by the codons UGU and UGC.

Site specific pegylated hemoglobin, method of preparing same, and uses thereof

InactiveUS20090215670A1Haemoglobins/myoglobinsPeptide/protein ingredientsThiolMedicine
The present invention provides pegylated hemoglobins comprising a maleimide polyethylene glycol (PEG) conjugated to a thiol moiety of a cysteine residue of hemoglobin, methods of preparing the pegylated hemoglobins, compositions and blood substitutes comprising the pegylated hemoglobins, and methods of treating a subject which comprise administering to the subject blood substitutes comprising vasoinactive pegylated hemoglobins.
Owner:ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIV

Compositions comprising sugar-cysteine products

InactiveUS20140348811A1Increasing ATP and glutathioneBiocideOrganic active ingredientsChemistryCysteine
The present invention provides compositions comprising sugar, cysteine, and / or sugar-cysteine products, methods of preparing the same, and / or using the same.
Owner:MAX INT LLC

Fluorescein derivative and synthetic method thereof

PendingCN114729352ASimple structureOrganic chemistryHydrolasesOxidative enzymeDehalogenase
The present disclosure relates to fluorescein derivatives and methods of synthesis of fluorescein derivatives. A method of synthesizing a fluorescein derivative includes performing a first reaction by using a toxic phenol derivative as a substrate, and reacting the toxic phenol derivative in a buffer solution by using a thermostable dehalogenase, a set of free radical scavenging enzymes, a set of polyphenol oxidase and an FADH2 generating system to obtain benzoquinone. The FADH2 generation system is capable of generating FADH2, which is a substrate for a thermostable dehalogenase. Furthermore, a second reaction is carried out between the derived benzoquinone and D-cysteine to obtain a fluorescein derivative capable of emitting light at a wavelength of 600-700 nm. Therefore, the fluorescein derivative can be used in various fields of medical research, drug research, other detection technologies and the like.
Owner:VIDYASIRIMEDHI INST OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products